{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:31Z","timestamp":1792787851610,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82300646"],"award-info":[{"award-number":["82300646"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Integrated Medical Association Clinical Research Funding Program","award":["ZHKY-2025-1869\uff08B012\uff09"],"award-info":[{"award-number":["ZHKY-2025-1869\uff08B012\uff09"]}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2020001\uff0cPX20240103"],"award-info":[{"award-number":["PX2020001\uff0cPX20240103"]}],"id":[{"id":"https:\/\/ror.org\/04baakq55","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-2-2028"],"award-info":[{"award-number":["2024-2-2028"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project Award","award":["No.2024ZD0520600"],"award-info":[{"award-number":["No.2024ZD0520600"]}]},{"name":"Beijing Natural Science Foundation","award":["7232334"],"award-info":[{"award-number":["7232334"]}]},{"name":"Beijing Municipal Science & Technology Commission AI+ Health Collaborative Innovation Cultivation Project","award":["Z241100007724004"],"award-info":[{"award-number":["Z241100007724004"]}],"id":[{"id":"https:\/\/ror.org\/034k14f91","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W162020100\uff0cBRWEP2024W162020112"],"award-info":[{"award-number":["BRWEP2024W162020100\uff0cBRWEP2024W162020112"]}]},{"name":"Excellent Plan for Medicine Innovation and Translation Project","award":["YC202401QX0824"],"award-info":[{"award-number":["YC202401QX0824"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05089-6","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:52:17Z","timestamp":1783929137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of gut-brain neuromodulators in functional esophageal disorders: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Zimeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"5089_CR1","unstructured":"Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology. 2016:S0016-5085(16)00178\u20135."},{"key":"5089_CR2","unstructured":"Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and rome iv. Gastroenterology. 2016:S0016\u20135085(16)00223\u20137."},{"issue":"7","key":"5089_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.cgh.2016.12.032","volume":"15","author":"MP Jones","year":"2017","unstructured":"Jones MP, Tack J, Van Oudenhove L, et al. Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin Gastroenterol Hepatol. 2017;15(7):1014\u201320.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"5089_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski NA, Jones M, Kalantar J, et al. The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284\u201390.","journal-title":"Gut"},{"issue":"10263","key":"5089_CR5","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","volume":"396","author":"CJ Black","year":"2020","unstructured":"Black CJ, Drossman DA, Talley NJ, et al. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396(10263):1664\u201374.","journal-title":"Lancet"},{"issue":"9","key":"5089_CR6","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1136\/gutjnl-2019-318308","volume":"68","author":"EA Mayer","year":"2019","unstructured":"Mayer EA, Labus J, Aziz Q, et al. Role of brain imaging in disorders of brain-gut interaction: a rome working team report. Gut. 2019;68(9):1701\u201315.","journal-title":"Gut"},{"issue":"6","key":"5089_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/nmo.12793","volume":"28","author":"IS Lee","year":"2016","unstructured":"Lee IS, Wang H, Chae Y, et al. Functional neuroimaging studies in functional dyspepsia patients: a systematic review. Neurogastroenterol Motil. 2016;28(6):793\u2013805.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"5089_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ajg.2017.57","volume":"112","author":"WH Sobin","year":"2017","unstructured":"Sobin WH, Heinrich TW, Drossman DA. Central neuromodulators for treating functional gi disorders: a primer. Am J Gastroenterol. 2017;112(5):693\u2013702.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"5089_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(25)00051-2","volume":"10","author":"M Khasawneh","year":"2025","unstructured":"Khasawneh M, Mokhtare M, Moayyedi P, et al. Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(6):537\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"5089_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","volume":"154","author":"DA Drossman","year":"2018","unstructured":"Drossman DA, Tack J, Ford AC, et al. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a rome foundation working team report. Gastroenterology. 2018;154(4):1140\u201371.","journal-title":"Gastroenterology"},{"key":"5089_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM, et al. The prisma 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"5089_CR12","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898.","DOI":"10.1136\/bmj.l4898"},{"issue":"3","key":"5089_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A, et al. Interrater reliability of the modified jadad quality scale for systematic reviews of alzheimer\u2019s disease drug trials. Dement Geriatr Cogn Disord. 2001;12(3):232\u20136.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"5089_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"key":"5089_CR15","doi-asserted-by":"crossref","unstructured":"Campbell M, Mckenzie JE, Sowden A, et al. Synthesis without meta-analysis (swim) in systematic reviews: reporting guideline. Bmj. 2020;368:l6890.","DOI":"10.1136\/bmj.l6890"},{"issue":"7650","key":"5089_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"5","key":"5089_CR17","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke","year":"1997","unstructured":"Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in olmsted county, minnesota. Gastroenterology. 1997;112(5):1448\u201356.","journal-title":"Gastroenterology"},{"issue":"9","key":"5089_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2036.2003.01557.x","volume":"17","author":"GD Eslick","year":"2003","unstructured":"Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting\u2013a population-based study. Aliment Pharmacol Ther. 2003;17(9):1115\u201324.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"5089_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/nmo.12231","volume":"25","author":"AD Farmer","year":"2013","unstructured":"Farmer AD, Coen SJ, Kano M, et al. Psychological traits influence autonomic nervous system recovery following esophageal intubation in health and functional chest pain. Neurogastroenterol Motil. 2013;25(12):772\u2013950.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"5089_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/emj.2005.025163","volume":"23","author":"NS Demiryoguran","year":"2006","unstructured":"Demiryoguran NS, Karcioglu O, Topacoglu H, et al. Anxiety disorder in patients with non-specific chest pain in the emergency setting. Emerg Med J. 2006;23(2):99\u2013102.","journal-title":"Emerg Med J"},{"key":"5089_CR21","doi-asserted-by":"crossref","unstructured":"Malik Z, Bayman L, Valestin J, et al. Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial. Dis Esophagus. 2017;30(2):1\u20138.","DOI":"10.1111\/dote.12455"},{"issue":"30","key":"5089_CR22","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3748\/wjg.v19.i30.4958","volume":"19","author":"SW Park","year":"2013","unstructured":"Park SW. Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain. World J Gastroenterol. 2013;19(30):4958.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"5089_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.pain.2010.08.040","volume":"152","author":"FJ Keefe","year":"2011","unstructured":"Keefe FJ, Shelby RA, Somers TJ, et al. Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study. Pain. 2011;152(4):730\u201341.","journal-title":"Pain"},{"issue":"7","key":"5089_CR24","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/ajg.2010.82","volume":"105","author":"H Lee","year":"2010","unstructured":"Lee H, Kim JH, Min B, et al. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol. 2010;105(7):1504\u201312.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"5089_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jpsychores.2010.02.005","volume":"69","author":"P Spinhoven","year":"2010","unstructured":"Spinhoven P, Van der Does AJW, Van Dijk E, et al. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine. J Psychosom Res. 2010;69(3):227\u201335.","journal-title":"J Psychosom Res"},{"issue":"5","key":"5089_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1572-0241.2007.01112.x","volume":"102","author":"SSC Rao","year":"2007","unstructured":"Rao SSC, Mudipalli RS, Remes-Troche JM, et al. Theophylline improves esophageal chest pain?a randomized, placebo-controlled study. Am J Gastroenterol. 2007;102(5):930\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5089_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.64719\/pb.4153","volume":"39","author":"PM Doraiswamy","year":"2006","unstructured":"Doraiswamy PM, Varia I, Hellegers C, et al. A randomized controlled trial of paroxetine for noncardiac chest pain. Psychopharmacol Bull. 2006;39(1):15\u201324.","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"5089_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1067\/mhj.2000.108514","volume":"140","author":"I Varia","year":"2000","unstructured":"Varia I, Logue E, Connor O. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J. 2000;140(3):367\u201372.","journal-title":"Am Heart J"},{"issue":"2","key":"5089_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/euhj.1997.0615","volume":"19","author":"ID Cox","year":"1998","unstructured":"Cox ID, Hann CM, Kaski JC. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J. 1998;19(2):250\u20134.","journal-title":"Eur Heart J"},{"issue":"20","key":"5089_CR30","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJM199405193302003","volume":"330","author":"ROR Cannon","year":"1994","unstructured":"Cannon ROR, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330(20):1411\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"5089_CR31","first-page":"1027","volume":"92","author":"RE Clouse","year":"1987","unstructured":"Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. Gastroenterol (New York N Y 1943). 1987;92(4):1027. A double-blind, placebo-controlled trial.","journal-title":"Gastroenterol (New York N Y 1943)"},{"issue":"4","key":"5089_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2011-300798","volume":"61","author":"F Zerbib","year":"2012","unstructured":"Zerbib F, Belhocine K, Simon M, et al. Clinical, but not oesophageal ph-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut. 2012;61(4):501\u20136.","journal-title":"Gut"},{"issue":"9","key":"5089_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gut.2008.175810","volume":"58","author":"E Savarino","year":"2009","unstructured":"Savarino E, Pohl D, Zentilin P, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58(9):1185\u201391.","journal-title":"Gut"},{"issue":"5","key":"5089_CR34","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cgh.2014.08.029","volume":"13","author":"A Patel","year":"2015","unstructured":"Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal ph-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2015;13(5):884\u201391.","journal-title":"Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association"},{"issue":"1","key":"5089_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365529509093228","volume":"30","author":"BT Johnston","year":"1995","unstructured":"Johnston BT, Lewis SA, Collins JS, et al. Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol. 1995;30(1):1\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"5089_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ajg.2015.413","volume":"111","author":"J Limsrivilai","year":"2016","unstructured":"Limsrivilai J, Charatcharoenwitthaya P, Pausawasdi N, et al. Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized placebo-controlled trial. Am J Gastroenterol. 2016;111(2):217\u201324.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"5089_CR37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nmo.12313","volume":"26","author":"MR Ostovaneh","year":"2014","unstructured":"Ostovaneh MR, Saeidi B, Hajifathalian K, et al. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo\u2010controlled trial. Neurogastroenterology Motil. 2014;26(5):670\u20138.","journal-title":"Neurogastroenterology Motil"},{"issue":"2","key":"5089_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00535-011-0480-0","volume":"47","author":"E Savarino","year":"2012","unstructured":"Savarino E, Zentilin P, Tutuian R, et al. Impedance-ph reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47(2):159\u201368.","journal-title":"J Gastroenterol"},{"issue":"4","key":"5089_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","volume":"17","author":"SD Martinez","year":"2003","unstructured":"Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (nerd)--acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17(4):537\u201345.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"5089_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.mucimm.2023.06.001","volume":"16","author":"MTA Kleuskens","year":"2023","unstructured":"Kleuskens MTA, Bek MK, Al Halabi Y, et al. Mast cells disrupt the function of the esophageal epithelial barrier. Mucosal Immunol. 2023;16(5):567\u201377.","journal-title":"Mucosal Immunol"},{"issue":"9","key":"5089_CR41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/gut.2007.120691","volume":"56","author":"JD S\u00f6derholm","year":"2007","unstructured":"S\u00f6derholm JD. Stress-related changes in oesophageal permeability: filling the gaps of gord? Gut. 2007;56(9):1177\u201380.","journal-title":"Gut"},{"issue":"11","key":"5089_CR42","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/ajg.2011.179","volume":"107","author":"N Viazis","year":"2012","unstructured":"Viazis N, Keyoglou A, Kanellopoulos AK, et al. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol. 2012;107(11):1662\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"5089_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.02772.x","volume":"23","author":"D Broekaert","year":"2006","unstructured":"Broekaert D, Fischler B, Sifrim D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo\u2010controlled study. Aliment Pharmacol Ther. 2006;23(3):365\u201370.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"5089_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/00365521.2014.966319","volume":"50","author":"AE Olesen","year":"2014","unstructured":"Olesen AE, Nielsen LM, Larsen IM, et al. Randomized clinical trial: efficacy and safety of ppc-5650 on experimental esophageal pain and hyperalgesia in healthy volunteers. Scand J Gastroenterol. 2014;50(2):138\u201344.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"5089_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2036.2011.04955.x","volume":"35","author":"YC Chua","year":"2012","unstructured":"Chua YC, Ng KS, Sharma A, et al. Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers \u2013 a placebo\u2010controlled study. Aliment Pharmacol Ther. 2012;35(3):319\u201326.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"5089_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gut.42.6.807","volume":"42","author":"PL Peghini","year":"1998","unstructured":"Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut. 1998;42(6):807\u201313.","journal-title":"Gut"},{"issue":"3","key":"5089_CR47","first-page":"G460","volume":"275","author":"AB Gorelick","year":"1998","unstructured":"Gorelick AB, Koshy SS, Hooper FG, et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol. 1998;275(3):G460\u20136.","journal-title":"Am J Physiol"},{"issue":"11","key":"5089_CR48","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/archotol.1982.00790590062017","volume":"108","author":"PJ Moloy","year":"1982","unstructured":"Moloy PJ, Charter R. The globus symptom. Incidence, therapeutic response, and age and sex relationships. Arch Otolaryngol. 1982;108(11):740\u20134.","journal-title":"Arch Otolaryngol"},{"issue":"6","key":"5089_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0022-3999(96)00024-4","volume":"40","author":"MB Harris","year":"1996","unstructured":"Harris MB, Deary IJ, Wilson JA. Life events and difficulties in relation to the onset of globus pharyngis. J Psychosom Res. 1996;40(6):603\u201315.","journal-title":"J Psychosom Res"},{"issue":"42","key":"5089_CR50","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.3748\/wjg.v19.i42.7455","volume":"19","author":"L You","year":"2013","unstructured":"You L. Effect of low-dose amitriptyline on globus pharyngeus and its side effects. World J Gastroenterol. 2013;19(42):7455.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"5089_CR51","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.dld.2016.05.025","volume":"48","author":"D Chen","year":"2016","unstructured":"Chen D, Jia L, Gu X, et al. Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Dig Liver Dis. 2016;48(9):1012\u20137.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"5089_CR52","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.dld.2017.02.008","volume":"49","author":"W Zhou","year":"2017","unstructured":"Zhou W, Jia L, Chen D, et al. The effects of paroxetine and amitriptyline on the upper esophageal sphincter (ues) pressure and its natural history in globus pharyngeus. Dig Liver Dis. 2017;49(7):757\u201363.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"5089_CR53","doi-asserted-by":"publisher","first-page":"e14500","DOI":"10.1111\/nmo.14500","volume":"35","author":"N Poovipirom","year":"2023","unstructured":"Poovipirom N, Ratta Apha W, Maneerattanaporn M, et al. Treatment outcomes in patients with globus: a randomized control trial of psychoeducation, neuromodulators, and proton pump inhibitors. Neurogastroenterology Motil. 2023;35(3):e14500.","journal-title":"Neurogastroenterology Motil"},{"issue":"1","key":"5089_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2273.1994.tb01148.x","volume":"19","author":"IJ Deary","year":"1994","unstructured":"Deary IJ, Wilson JA. Problems in treating globus pharyngis. Clin Otolaryngol. 1994;19(1):55\u201360.","journal-title":"Clin Otolaryngol"},{"issue":"5","key":"5089_CR55","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00405-020-06544-0","volume":"278","author":"N Takahashi","year":"2021","unstructured":"Takahashi N, Ikeda K, Iwai G, et al. Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (proms). Eur Arch Otorhinolaryngol. 2021;278(5):1483\u20139.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"9","key":"5089_CR56","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E, et al. U.s. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569\u201380.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"5089_CR57","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.14309\/ctg.0000000000000511","volume":"13","author":"P Lu","year":"2022","unstructured":"Lu P, Chen C, Wu J, et al. Clinical characteristics and associated psychosocial dysfunction in patients with functional dysphagia: a study based on high-resolution impedance manometry and rome iv criteria. Clin Transl Gastroenterol. 2022;13(7):e511.","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"5089_CR58","first-page":"1459","volume":"130","author":"JP Galmiche","year":"2006","unstructured":"Galmiche JP, Clouse RE, B\u00e1lint A, et al. Funct esophageal disorders Gastroenterol. 2006;130(5):1459\u201365.","journal-title":"Funct esophageal disorders Gastroenterol"},{"issue":"4","key":"5089_CR59","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00455-024-10770-7","volume":"40","author":"S Yoo","year":"2025","unstructured":"Yoo S, Bonilha HS, Hong I. Association between dysphagia and depressive symptoms: propensity score matching approaches. Dysphagia. 2025;40(4):728\u201336.","journal-title":"Dysphagia"},{"issue":"2","key":"5089_CR60","doi-asserted-by":"publisher","first-page":"e13213","DOI":"10.1111\/nmo.13213","volume":"30","author":"N Aggarwal","year":"2018","unstructured":"Aggarwal N, Thota PN, Lopez R, et al. A randomized double-blind placebo\u2010controlled crossover\u2010style trial of buspirone in functional dysphagia and ineffective esophageal motility. Neurogastroenterology Motil. 2018;30(2):e13213.","journal-title":"Neurogastroenterology Motil"},{"issue":"8","key":"5089_CR61","doi-asserted-by":"publisher","first-page":"e13632","DOI":"10.1111\/nmo.13632","volume":"31","author":"AC Manolakis","year":"2019","unstructured":"Manolakis AC, Broers C, Geysen H, et al. Effect of citalopram on esophageal motility in healthy subjects\u2014implications for reflux episodes, dysphagia, and globus. Neurogastroenterology Motil. 2019;31(8):e13632.","journal-title":"Neurogastroenterology Motil"},{"issue":"3","key":"5089_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MCG.0b013e318167b89d","volume":"43","author":"W Blonski","year":"2009","unstructured":"Blonski W, Vela MF, Freeman J, et al. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43(3):253\u201360.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"5089_CR63","first-page":"483","volume":"87","author":"S Singh","year":"1992","unstructured":"Singh S, Bailey RT, Stein HJ, et al. Effect of alprazolam (xanax) on esophageal motility and acid reflux. Am J Gastroenterol. 1992;87(4):483.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"5089_CR64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.14309\/ajg.0000000000002800","volume":"119","author":"I Hanna-Jairala","year":"2024","unstructured":"Hanna-Jairala I, Drossman DA. Central neuromodulators in irritable bowel syndrome: why, how, and when. Am J Gastroenterol. 2024;119(7):1272\u201384.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"5089_CR65","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/apt.16588","volume":"54","author":"I Kotikula","year":"2021","unstructured":"Kotikula I, Thinrungroj N, Pinyopornpanish K, et al. Randomised clinical trial: the effects of pregabalin vs placebo on functional dyspepsia. Aliment Pharmacol Ther. 2021;54(8):1026\u201332.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5089_CR66","first-page":"6","volume":"36","author":"T Voulgaris","year":"2023","unstructured":"Voulgaris T, Lekakis V, Vlachogiannakos J, et al. Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain. Ann Gastroenterol. 2023;36(1):6\u201311.","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"5089_CR67","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","volume":"20","author":"R Yadlapati","year":"2022","unstructured":"Yadlapati R, Gyawali CP, Pandolfino JE. Aga clinical practice update on the personalized approach to the evaluation and management of gerd: expert review. Clin Gastroenterol Hepatol. 2022;20(5):984\u201394.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"5089_CR68","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1053\/j.gastro.2020.01.034","volume":"158","author":"R Fass","year":"2020","unstructured":"Fass R, Zerbib F, Gyawali CP. Aga clinical practice update on functional heartburn: expert review. Gastroenterology. 2020;158(8):2286\u201393.","journal-title":"Gastroenterology"},{"issue":"17","key":"5089_CR69","doi-asserted-by":"publisher","first-page":"105281","DOI":"10.3748\/wjg.v31.i17.105281","volume":"31","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhou J, Wu H, et al. Clinical characteristics and risk factors of esophageal reflux hypersensitivity: a multicenter study. World J Gastroenterol. 2025;31(17):105281.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"5089_CR70","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.dld.2024.05.013","volume":"56","author":"J Yeh","year":"2024","unstructured":"Yeh J, Chen C, Sifrim D, et al. Central neuromodulators for patients with functional esophageal disorders: a systematic review and meta-analysis. Dig Liver Dis. 2024;56(10):1675\u201382.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"5089_CR71","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000484202","volume":"97","author":"Y Liu","year":"2018","unstructured":"Liu Y, Jia L, Jiang S, et al. Serotonin transporter gene (slc6a4) polymorphism may be associated with chinese globus pharyngeus and its antidepressant effects. Digestion. 2018;97(2):146\u201353.","journal-title":"Digestion"},{"issue":"5","key":"5089_CR72","doi-asserted-by":"publisher","first-page":"104421","DOI":"10.1016\/j.amjoto.2024.104421","volume":"45","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lan Q, Zheng E, et al. Efficacy analysis of the empathy-based attribution analysis-cognitive restructuring-pharmacological treatment model in the management of globus syndrome. Am J Otolaryngol. 2024;45(5):104421.","journal-title":"Am J Otolaryngol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05089-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:55Z","timestamp":1791378175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5089"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05089-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. All authors read and approved the final manuscript.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"619"}}